A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer

por Boutros, C, Mazouni, C, Lerebours, F, Stevens, D, Lei, X, Gonzalez-Angulo, A M, Delaloge, S
Publicado 2015

Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy

por Gonzalez-Angulo, A M, Parinyanitikul, N, Lei, X, Mittendorf, E A, Zhang, H, Valero, V, Hunt, K K, Hortobagyi, G N, Chavez-MacGregor, M
Publicado 2015

Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients

por Cheng, Y C, Valero, V, Davis, M L, Green, M C, Gonzalez-Angulo, A M, Theriault, R L, Murray, J L, Hortobagyi, G N, Ueno, N T
Publicado 2010

A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer

por Bastos, E. P., Brentani, H., Pereira, C. A. B., Polpo, A., Lima, L., Puga, R. D., Pasini, F. S., Osorio, C. A. B. T., Roela, R. A., Achatz, M. I., Trapé, A. P., Gonzalez-Angulo, A. M., Brentani, M. M.
Publicado 2016